Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06895681 · ClinicalTrials.gov registry record
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
A clinical trial, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- 50,000
- Enrollment target
NCT06895681 is a clinical trial that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 50,000 participants.
The verdict
NCT06895681 has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
Study Summary
This is a non-therapeutic clinical research biorepository protocol designed to obtain, store, and clinically annotate biospecimens from participants with hereditary cancers. Those biospecimens will be used to generate participant-derived tumor models that will serve as a resource to better understand hereditary cancers and develop new efficient therapies.
Interventions
- OTHER Medical Chart Review
- PROCEDURE Blood Sample
- PROCEDURE Tissue Sample
- PROCEDURE Excess fluid Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2026-08-31 |
| Est. Completion | 2035-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06895681
The ClinicalTrials.gov registry entry for NCT06895681 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Medical Chart Review is the first listed.
NCT06895681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06895681 about?
NCT06895681 is a clinical study titled "UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations". This is a non-therapeutic clinical research biorepository protocol designed to obtain, store, and clinically annotate biospecimens from participants with hereditary cancers. Those biospecimens will be used to generate participant-derived tumor models that will serve as a resource to better understan...
What is the current status of trial NCT06895681?
This trial is currently not yet recruiting. The enrollment target is 50,000 participants. The study started on 2026-08-31. Estimated completion is 2035-12-31.
What interventions are being tested in trial NCT06895681?
The interventions under investigation include: Medical Chart Review (OTHER), Blood Sample (PROCEDURE), Tissue Sample (PROCEDURE), Excess fluid Sample (PROCEDURE).
Who is sponsoring clinical trial NCT06895681?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.